JPRN-UMIN000005578
Completed
Phase 2
A phase II trial of Neoadjuvant and adjuvant chemotherapy with Gemcitabine and TS-1 combination for patients with locally advanced pancreatic cancer - CAP-003
Chiba study group of adjuvant chemotherapy for pancreatic cancer0 sites45 target enrollmentMay 10, 2011
Conditionspancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- pancreatic cancer
- Sponsor
- Chiba study group of adjuvant chemotherapy for pancreatic cancer
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) History of sever allergic reaction with gemcitabine or s\-1 2\)Sever myelosuppression 3\) Pregnant females, possibly pregnant females, females wishing to become pregnant, and females feeding babies. 4\)Serious renal dysfunction 5\)Serious liver dysfunction 6\)Patients under treatment with other furuorouracil related chemotherapy 7\)Patients under treatment with flucytosine. 8\)Pulmonary fibrosis or interstitial pneumonia 9\)History of breast or lung radiation 10\)Active infection 11\)Patients with pleural effusion 12\)Evidence of distant metastasis 13\)Active double cancer 14\)Uncontrolled heart diseases such as angina, myocardial infarction within three months, and cardiac dysfunction 15\)Uncontrolled diabetes or hypertension 16\)Sever mental disorder 17\)Inadequate physical condition, as diagnosed by primary physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A phase II study of Neoadjuvant chemotherapy plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage ovarian cancer (TRU-D)NeoplasmsKCT0003742Yonsei University Health System, Severance Hospital24
Active, Not Recruiting
Phase 1
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancerMedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-004515-45-ESFundación GECP90
Active, Not Recruiting
Phase 1
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2024-513731-24-00Fundacion GECP90
Recruiting
N/A
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
Unknown
Phase 2
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25